Results 141 to 150 of about 16,979 (251)

An uncommon multimodal management approach for low-grade appendiceal mucinous neoplasm with pseudomyxoma peritonei and mucinous borderline ovarian tumor. [PDF]

Ann Med Surg (Lond)
Singh DK, Dhakal I, Ghimire S, Pandit N, Sharma R, Dulal S.   +5 more
europepmc   +1 more source

AI‐Based Analysis of Tumor‐Infiltrating Lymphocytes and Homologous Recombination in Ovarian Cancer: JGOG3025‐A1 Study

Cancer Science, EarlyView.
AI‐based spatial analysis of tumor‐infiltrating lymphocytes in ovarian cancer revealed the highest infiltration in high‐grade serous carcinoma. Integrating pathology‐based immune phenotypes with HRD status provided additional prognostic insight and highlighted distinct relationships between TILs and genomic structure.
Kohei Hamada, Junzo Hamanishi, Noriomi Matsumura, Akihiko Ueda, Shiro Takamatsu, Kosuke Yoshihara, Takayuki Nagasawa, Toshiyuki Seki, Akira Kikuchi, Etsuko Fujimoto, Mana Taki, Koji Yamanoi, Ryusuke Murakami, Hisaaki Kudo, Katsutoshi Oda, Muneaki Shimada, Aikou Okamoto, Masaki Mandai   +17 more
wiley   +1 more source

Giant Mucinous Borderline Ovarian Tumor With Microinvasion Presenting As Massive Ascites and Acute Respiratory Compromise: A Case Report. [PDF]

Cureus
Flindris S, Styliara E, Galaziou G, Petousis S, Margioula-Siarkou C, Paschopoulos M, Navrozoglou I.   +6 more
europepmc   +1 more source

Primary female genital system lymphoma complicated by a recurrent mucinous borderline ovarian tumor: a case report and review of the literature. [PDF]

BMC Womens Health, 2021
Du E, Qu X, Xu W, Lu H.
europepmc   +1 more source

Advances in Radiotherapy for Neoadjuvant Therapy of Stage III Non‐Small Cell Lung Cancer

Cancer Science, EarlyView.
This review summarizes three neoadjuvant radiotherapy techniques for stage III NSCLC, highlighting SFRT's low‐toxicity dual immune‐tumor control benefits and radioimmunotherapy's superior pathological response to guide precise multimodal treatment. ABSTRACT This review aims to systematically summarize the mechanisms of action, clinical evolution, and ...
Qinrong Mao, Yuanchun Yu, Yan Fang, Shaofeng Zhu, Chengjin Tang, Jing Cai   +5 more
wiley   +1 more source

Random forest-based model for the recurrence prediction of borderline ovarian tumor: clinical development and validation. [PDF]

J Cancer Res Clin Oncol
Yan L, Ye Q, Shi B, Liu J, Hu Y, Liu O, Li X, Lin B, Qi Y.   +8 more
europepmc   +1 more source

Advances in Spatial Heterogeneity and Cellular Localization Specificity of Intratumoral Bacteria

Cancer Science, EarlyView.
Spatial localization of intratumoral bacteria governs their functional roles in tumor progression, metastasis, and treatment responses, with guiding significance for clinical management, as reviewed across three spatial paradigms. ABSTRACT Bacteria in tumors are increasingly recognized to be a part of the tumor microenvironment and their biological ...
Minlan Ren, Jing Jia, Tingting Li, Yiwei Li, Nanxiang Shen, Yun Shi, Zhe Wang, Hao Fan, Guangli Sun, Guanying Xiong, Gang Li, Rui Peng   +11 more
wiley   +1 more source

Giant mucinous borderline ovarian tumor: challenges of diagnosis and treatment. [PDF]

Arch Gynecol Obstet
Sadlecki P, Dejewska K, Domieracka P, Walentowicz-Sadlecka M.   +3 more
europepmc   +1 more source

Single‐Cell and Spatial Analysis Reveal the Differences Between Left‐Sided and Right‐Sided Colorectal Cancer

Cell Proliferation, EarlyView.
Single‐cell and spatial analysis revealed distinct CRC microenvironments by tumour laterality. Right‐sided tumours showed enhanced germinal centre B cells, CXCL13+ T cells, and organized TLS‐immune crosstalk via CCL19/21‐CCR7, suggesting better immunotherapy response.
Zongnai Zhang, Jiaqi Xu, Yingchao Wu, Tao Liu, Junling Zhang, Mai Zhou, Jie Qiao, Heng Pan, Xin Wang   +8 more
wiley   +1 more source

Case Report: Serous borderline ovarian tumor and extensive abdominopelvic endometriosis mimicking advanced epithelial ovarian cancer in a postmenopausal patient. [PDF]

Front Med (Lausanne)
Livatova K, Nguyen AD, Pizzuti J, Lee YC, McEachron J.   +4 more
europepmc   +1 more source